LSI

Last week CMR Surgical announced the successful closing of a financing round of over $200 million through a combination of equity and debt capital to support the company’s ambitious growth plans. The fundraising, which was supported by all the company’s existing major investors, includes a new debt investment from Trinity Capital, reflecting strong investor confidence in CMR’s vision. CMR will use the funds to accelerate commercial expansion of the Versius Surgical Robotic System to more hospitals around the world – with a major focus on launching Versius in the United States – and to continue advancing surgical robotics innovation and product development, including the launch of the newly enhanced Versius Plus. To hear more from the CMR Surgical team tune into the full LSI Europe ‘23 Keynote, “Size, Modularity, Portability, Versatility: CMR Surgical's Vision to Scale Robotics so More Patients Can Receive Minimal Access Surgery” featuring Mark Slack, Luke Hares, and Supratim Bose, on our website and YouTube channel. Want to get involved at LSI Europe ‘25? Spots are limited and filling fast. Apply to present or register today on our website for your opportunity to connect with the industry's top decision-makers at LSI Europe ‘25 on September 7-11, 2025 in London.

As LSI Europe ‘25 approaches, we’re showcasing the innovators from around the globe who are selected to present in London this September. Today we’re showcasing: 1. Upma Sharma, PhD — Arsenal Medical → Develops purpose-built biomaterials to solve challenging and underserved medical problems. The company’s lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage. 2. Francis White — Heart Biotech Nano Ltd → The company's Yacoub Heart Valve is a unique, tissue-engineered valve that promises to revolutionize heart valve replacement with no compromises. Using intricate scaffold technology that transforms in-situ into a living heart valve, using the body’s own healing processes to regenerate as nature intended. Restoring full life expectancy and in kids, adapting and growing. 3. Ray Liu — Vena Vitals → Focused on non-invasive continuous blood pressure monitoring. The company's proprietary technology is a soft flexible sensor that conforms to the skin for direct pressure measurement at the radial artery. The company's technology is intended to replace unnecessarily invasive arterial line measurements as well as non-continuous cuff-based methods in both the hospital and at home. We look forward to seeing these innovators take the stage September 7-11 in London. Interested in presenting at the event? Apply to present on our website today.

Continuing with the ABCs of LSI USA ‘25 — Today’s letter of the day is J for Joe Kiani. Joe Kiani is committed to transforming yesterday's impossibilities into today’s realities. This is precisely what he accomplished at Masimo® and continues to achieve with Willow Laboratories, which was founded in 1998. Kiani founded Masimo in 1989, a global medical technology company renowned for noninvasive patient monitoring technologies. Under his leadership as Chairman and CEO, Masimo transformed from a “garage start-up” into a publicly traded, multi-billion-dollar enterprise listed on NASDAQ (MASI). Joe’s LSI USA ‘25 Keynote is now available: https://lnkd.in/ebN66vxm Stay tuned on our website, YouTube, and LinkedIn as we continue rolling out more keynotes, panels, workshops, and presentations from LSI USA ’25 in the days and weeks ahead. #LSIUSA25

LSI Europe ’25 is right around the corner and so might be your next partner, investor, or fund returner. But don't just take it from us. Hear directly from LSI Alumni and the real impact LSI events have made on their businesses. 1. €44M Series B Co-led by Panakes Partners and Broadview Ventures Inc “I was introduced to our first lead investor at LSI Europe. Later at LSI USA, I met with others who joined our syndicate. I also met fellow CEOs who gave sage advice, and credit a chance encounter in the lobby for the search firm who helped out first US hires.” - Paul Mead, CEO of CorFlow 2. Qaelon Medical and RevMedica Announce Data Partnership “At LSI Europe ‘24, a casual dinner conversation and brainstorming session with a panelist evolved into a significant opportunity, expanding Qaelon’s footprint and ultimately leading to our new data partnership with RevMedica.” - Liam J. Burns, CEO of Qaelon Medical 3. TVM Capital Life Science Co-led Vektor Medical, Inc.’s $25M Series A “During LSI Europe we had the opportunity to meet with the management team of Vektor Medical. It was their team's clear vision for their vMap product that motivated us to dive deeper and ultimately invest. Their commitment and drive were the catalyst for our belief in Vektor's groundbreaking product.” - Dr. Luc Marengere, Managing Partner at TVM Capital Life Science 4. Panakes Partners Co-led Lymphatica Medtech’s €17.9M Series B "I met Lymphatica at LSI Europe '23 in Barcelona. LSI helped me discover the opportunity and exchange ideas with potential co-investors about the disease and solution.” - Alessio Beverina, Co-Founder & General Partner at Panakes Partners 5. Scalpel AI Announced $4.8M Funding Round Led by Mercia Ventures “I first connected with Robert Hornby at LSI Europe ‘23, which led to our initial introduction to Mercia Ventures. While the timing wasn’t right then, the LSI connection put Scalpel on Mercia's radar. We were reintroduced six months later and Mercia chose to invest.” - Yeshwanth Pulijala, Founder & CEO of Scalpel AI Ready to get involved at LSI Europe '25? Spots are limited and filling fast. Apply to present or register today for your opportunity to connect with the industry's top decision-makers at LSI Europe ‘25 on September 7-11, 2025 in London: https://lnkd.in/ggdC2dnt

Hot off the press! The latest edition of our weekly newsletter The Memo, featuring James Lancaster, CEO and Chairman of Solenic Medical Inc. is out now! Under the direction of CEO and Chairman James Lancaster, Solenic Medical is pioneering a radically noninvasive approach to a devastating healthcare challenge: prosthetic joint infections (PJIs). With a platform that uses alternating magnetic fields to generate targeted heat on metallic implants, Solenic offers a new way to disrupt bacterial biofilms—without surgery, synergistic with the standard of care use of antibiotics, and without compromise. “We’re the only non-surgical treatment for these infections,” Lancaster said. “And the outcomes we’re aiming to prevent—loss of limb or even life—are unfortunately far too common.” As the company prepares to expand clinical studies and make plans for global markets, it’s bringing new hope to thousands of patients who currently face repeat surgeries, mobility loss, and grim survival odds. Continue Reading: https://lnkd.in/giFVEAkU James Lancaster has been selected to present at LSI Asia '25 this June 10-13. Join us in welcoming Lancaster to the event in Singapore, where he will share the latest updates on Solenic Medical’s technology and development.

Did you know that APAC, currently second largest regional medtech market ($131 billion in 2023), is growing at nearly double the compound annual growth rate (CAGR) of both the United States and Europe? APAC medtech is projected to grow at a robust CAGR of 8.4% from 2023 to 2028. This week's edition of The Numbers — our weekly, no-fluff series with market data and insights from LSI's trusted Market Intelligence team — dives into the APAC medtech market, the history of medtech in the region, the numbers driving it today from Market Intelligence, by LSI, companies we're watching, and more. Nousq Pte Ltd | KēlaHealth | Bionic Vision Technologies | Wellumio | Heteron Biotechnologies, LLC Subscribe to The Numbers here on LinkedIn for weekly market intelligence, and let us know what you'd like to see covered next. PS - Registration, presenter applications, speaker submissions, and sponsorships are open for LSI Asia '25. With new partnerships spanning Singapore, China, Korea, Japan, and more, this event will convene world-class startups, venture capital and private equity investors, strategics, and thought leaders. www.lsiasiasummit.com

Available now: Can Everyone Really Win? Deal Making with Strategics, Health Systems, and Investors Watch the full LSI USA ‘25 panel featuring John Hart, MBA➕, Biren Mehta, Lana B. Caron, Chris Terry, and Mayank Taneja here: https://lnkd.in/gmFyGcqr Stay tuned as we continue rolling out more keynotes, panels, workshops, and presentations from LSI USA ’25 in the days and weeks ahead on our website, YouTube, and LinkedIn. #LSIUSA25

April’s just started, and the LSI Alumni are already in full bloom 🌻 This week the #LSIAlumni secured over $235M in funding, received FDA 510(k) clearances, appointed new executives, and much more on the road to LSI Asia ‘25. Your 60-second news recap: Append Medical — Nadav Agian → Appointed Shlomi Nachman as Chairman of the Board Calla Lily Clinical Care — Thang Vo-Ta, Lara Zibners MD MMEd MBA → Secured £1M in NIHR funding to advance Callavid, a novel device designed to improve progesterone delivery for women experiencing threatened miscarriage. Cagent Vascular — Carol Burns → Announced a strategic partnership with 3comma Medical to expand international distribution of its Serranator PTA Serration Balloon Product Family across the EU and MENA regions. CMR Surgical — Luke Hares, Mark Slack, Supratim Bose → Raised over $200M in a financing round supported by existing investors and new investor Trinity Capital. CorWave — Louis de Lillers → Appointed Dawn Sadlowski-Buisserez as Vice President of Operations. Epitel — Mark Lehmkuhle → Received expanded FDA 510(k) clearance for its REMI™ Wireless EEG System, now approved for use in infants and children one year of age and older. FineHeart — arnaud Mascarell, Jean-Luc Boulnois → Appointed Sebastien ROBITAILLE as Chief Financial Officer. Methinks AI — Pau Rodríguez → Announced a strategic partnership with Medtronic to integrate its AI-powered stroke assessment platform into Medtronic’s Neurovascular portfolio across Central and Eastern Europe, the Middle East, Africa, and Türkiye. Nalu Medical — Thomas A. West, Jeff Swiecki → Appointed veteran medtech executive Raymond W. Cohen as Chairman of the Board of Directors. Navigation Sciences — Alan Lucas → Welcomed Heather Hudnut Page to its Advisory Board. NOVADIP Biosciences — Denis Dufrane → Appointed Soumya C. as Chief Financial Officer. Osteoboost (Bone Health Technologies) — Laura Yecies → Received FDA De Novo classification in January 2024 for its novel, non-drug vibration therapy device to address low bone density. PulmoTech — Rutger Flink, Niels van Rheenen → Announced Sentec has acquired PulmoTech BV. Restor3d — Ken Gall → Secured $38M in growth capital and received FDA 510(k) clearance for the iTotal Identity™ CR 3DP Porous Total Knee Replacement System. SamanTree Medical — Olivier Delporte → Closed a Series B extension round led by Karista, bringing the total financing to $20M. Vascular Perfusion Solutions — Rafael J. Veraza, PhD, MPH, Toni Hänninen → Appointed Dawn Bitz to its Strategic Board of Advisors. Zeto — Aswin Gunasekar → Unveiled NeuroPulse, the first AI-powered status epilepticus detection software using full 10-20 EEG, developed in collaboration with the Austrian Institute of Technology’s Encevis EEG analysis software. Congratulations to all the LSI Alumni who made major news this week!

The ABCs of LSI USA ‘25 — Today’s letter of the day is I for Investors. During these sessions, we heard directly from investors and strategics about what they’re looking for, where they’re placing bets, and how startups can stand out. From building the right foundation in “Access Granted”, to exploring founder-investor dynamics in “Do the Best Operators Really Need You?”, these conversations covered the full spectrum. “Investors and Strategics After Dark” offered an unfiltered look at how decisions really get made, while “How to Build a Clear Path to Revenue” connected early business traction with long-term investor interest. Access Granted — How to Attract Investors and Corporate Allies for Your Startup • Timothy Sheflin — Vice President, Veranex • Dustin Atkinson — Senior Director - Commercial Strategy & Market Access, Veranex • Adam Rosenwach — Chief Business Officer, Deerfield Catalyst Investors and Strategics After Dark • Dennis McWilliams — Managing Director, Sante • Matthew Schopp — Senior Director Business Development, Zimmer Biomet • Kate Garrett — Managing Director, Sonder Capital • Assaf Barnea — Managing Partner, Sanara Capital • Giles Hamilton — CEO, Chairman, Operating Partner & advisor Investors — Do The Best Operators Really Need You? • Dr. Luc Marengere — Managing Partner, TVM Capital Life Science • Rebecca Raabe — Founder & Investment Partner, SPRIG Equity • Tal Wenderow — Managing Partner, Star51 Capital • Megan MacDonagh — Ally Bridge • Vishal Gulati — Founder & Managing Partner, Recode Ventures How to Build a Clear Path to Revenue that Attracts Investors and Acquirers • Alex Wakefield — Chief Revenue Officer, AcuityMD • Jeff Byrne — Chief Financial Officer, Artelon • Andrew Morris — Chief Commercial Officer, MY01 The video recordings of these sessions will be available in the coming weeks. Tune in each day as we recap LSI USA ‘25 from A to Z. PS: Registration is now open for LSI USA ‘26 next March 16-20 in Dana Point, California. Secure your spot early to take advantage of our best rates and have first priority for our hotel room block.

Jinghua(Michael) Wang will be a featured speaker at LSI Asia ‘25, taking place June 10-13 in Singapore. As Managing Director of Greater China Ventures at Medtronic, Michael plays a pivotal role in shaping the Medtech investment landscape in China. In this role, he is instrumental in steering Medtronic's investment strategies within the Chinese market, focusing on fostering partnerships and identifying opportunities that align with the company's mission to deliver innovative healthcare solutions. With a robust background in venture capital and corporate strategy, Michael has been pivotal in bridging collaborations between emerging medtech startups and established industry leaders. His efforts have significantly contributed to the advancement and accessibility of cutting-edge medical technologies in the region. We’re thrilled to have Michael take the stage this June. Want to get involved in LSI Asia ‘25? Submit your application to present, exhibit, and attend the event. Apply today while space is still available: https://lnkd.in/gRmBtSVy